19 Nov CBD-based Product Leader Elixinol, LLC Joins ValidCare Community for Ongoing Product and Consumer Experience Insights
U.S. Health and wellness consumers will track real-time experiences related to their use of Elixinol’s broad range of CBD-based products, helping to create aggregated insights
Centennial, Colo. – November 19, 2019 – Elixinol, LLC, a U.S. subsidiary of Elixinol Global (EXL), has entered into an agreement with ValidCare, LLC, to help advance their goals of providing exceptional products, world-class customer support, and ongoing education and information to health and wellness consumers. ValidCare has created a collaborative, online global community to bring together product suppliers and developers with consumers to study, educate, and develop ongoing insights into the effects of CBD-based products.
Elixinol was founded in 2014 by leaders with broad ranging global business experience who share a commitment to creating and delivering the highest quality hemp-based CBD products. The Elixinol team brings over 25 years of relationships with hemp farmers around the globe, and today, they develop top-quality cultivars of hemp, organically grown and naturally processed to exceed industry standards. Elixinol produces only the highest-quality and maximum purity cannabidiol (CBD) and hemp products.
ValidCare connects, collects and informs the canna-based product industry, uncovering the health benefits of CBD products through community-based technology. ValidCare provides:
- Cross industry collaboration
- Innovative technology with advanced machine learning
- Visibility into aggregated, real-time data on the health benefits of CBD products
- Standardization of product identification
- The ability to improve the health of humans and animals using CBD products
“We’re committed to being the worldwide company of choice for cannabinoid and hemp products,” said Gabriel Ettenson, President of Elixinol, LLC. “Our vision is to educate, inspire, and empower others throughout the world to live naturally healthy, happy lives. Because we do this by providing the highest quality natural products, we want to give our health and wellness-focused consumers the opportunity to continually share their experiences and inform our ongoing product development efforts. Through the ValidCare platform, we are able to provide user education and product information, and our customers are able to track their experiences as they use the Elixinol products. The resulting insights will help us continually build excellence in our products.”
“We are excited to team with Elixinol, LLC, an organization which represents a true commitment to customer experience,” said Patrick McCarthy, CEO, ValidCare. “We share many mutual goals, as we work together to capture the consumer insights that will help advance the canna-based product industry. Our industry collaboration platform is supporting research, capturing experience data and delivering the insights needed by the CBD industry to effectively direct product development and treatment options. Through these efforts, we can help organizations like Elixinol grow an even deeper understanding of their customers and fuel their efforts to create the world’s best CBD-based products.”
ValidCare brings together businesses, research organizations, clinicians and others in the canna-based product community to improve consumer experiences resulting from these products. ValidCare provides Insights-as-a-Service via technology that includes a trusted, secure private network, advanced machine learning, and a proprietary user interface to build shared knowledge and power product development.
# # #
About ValidCare, LLC
ValidCare, LLC is the cannabinoid (CBD) industry’s Insights-as-a-Service company, connecting the global canna-based product community, collecting experiential data to drive product development and informing the community on CBD’s impact on health. The ValidCare platform offers a trusted and secure private network where product suppliers and developers, researchers, clinicians, and product users and their families come together to study, educate, measure and document the consumer experience with cannabinoid treatments. ValidCare’s CBD+Me proprietary app supports ongoing two-way communication, combining consumer-reported data with advanced machine learning to deliver insights that help accelerate validated treatment options.
For more information, visit www.validcare.com or call 844-825-4322.